Evaluation of Oxaliplatin and Gemcitabine in Patients With Metastatic Bladder Cancer
Condition(s):Carcinoma, Transitional CellLast Updated:August 21, 2023Terminated
Hide Studies Not Open or Pending
Condition(s):Carcinoma, Transitional CellLast Updated:August 21, 2023Terminated
Condition(s):Glial Tumor of Brain; Diffuse Intrinsic Pontine Glioma; GliomaLast Updated:November 27, 2019Withdrawn
Condition(s):Pancreatic CancerLast Updated:May 2, 2019Terminated
Condition(s):Pancreatic CancerLast Updated:November 5, 2020Terminated
Condition(s):Cervical CancerLast Updated:December 28, 2023Recruiting
Condition(s):Diffuse Intrinsic Pontine GliomaLast Updated:March 4, 2024Active, not recruiting
Condition(s):Meningitis; NeoplasmsLast Updated:November 12, 2012Terminated
Condition(s):Recurrent Ovarian Epithelial Cancer; Recurrent Fallopian Tube Carcinoma; Recurrent Primary Peritoneal CarcinomaLast Updated:April 30, 2018Completed
Condition(s):Malignant Neoplasm of Bone and Articular Cartilage; Malignant Neoplasms of Female Genital Organs; Malignant Neoplasms of Independent (Primary) Multiple Sites; Malignant Neoplasms of Lip Oral Cavity and Pharynx; Malignant Neoplasm of Male Genital Organs; Malignant Neoplasms of Mesothelial and Soft Tissue; Malignant Neoplasm of Respiratory and Intrathoracic Organ Carcinoma; Malignant Neoplasms of Thyroid and Other Endocrine Glands; Malignant Neoplasms of Urinary Tract; Melanoma and Other Malignant Neoplasms of SkinLast Updated:December 1, 2023Recruiting
Condition(s):Lymphoma; Solid NeoplasmLast Updated:July 25, 2022Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.